Harpoon Therapeutics Inc. (HARP)
NASDAQ: HARP
· Real-Time Price · USD
23.01
0.02 (0.09%)
At close: Mar 08, 2024, 10:00 PM
Harpoon Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -2.21 | 6.30 | -0.57 | -0.34 | -0.7 | -0.91 | -2.01 | -2.86 | -3.86 | -6.72 | -2.68 |
PEG Ratio | 0.01 | -0.06 | 0.01 | -0.01 | 0.02 | 0.06 | 0.32 | -0.1 | 2.01 | 0.09 | -0.01 |
PS Ratio | 3.58 | 1.32 | 3.20 | 5.98 | 2.36 | 7.60 | 27.67 | 57.09 | 57.50 | 77.23 | 73.35 |
PB Ratio | 3.50 | 8.92 | 38.47 | 4.53 | 1.90 | 2.37 | 3.95 | 4.25 | 3.35 | 4.96 | 6.45 |
P/FCF Ratio | -0.96 | -1.76 | -1.43 | -1.33 | -1.32 | -2.91 | -6.63 | -14.62 | -12.47 | -6.77 | -36.45 |
P/OCF Ratio | -0.96 | -1.76 | -1.43 | -1.33 | -1.34 | -2.92 | -6.47 | -14.67 | -12.47 | -6.77 | -36.55 |
OCF/S Ratio | -3.72 | -0.75 | -2.25 | -4.5 | -1.76 | -2.6 | -4.27 | -3.89 | -4.61 | -11.4 | -2.01 |
Debt / Equity Ratio | 3.19 | 5.06 | 21.83 | 2.96 | 0.65 | 0.43 | 0.29 | 0.21 | 0.16 | 0.14 | 0.13 |
Quick Ratio | 1.89 | 1.94 | 1.45 | 1.04 | 1.28 | 1.62 | 2.00 | 2.33 | 2.82 | 3.21 | 2.39 |
Current Ratio | 1.89 | 1.94 | 1.45 | 1.04 | 1.28 | 1.62 | 2.00 | 2.33 | 2.82 | 3.21 | 2.39 |
Asset Turnover | 0.09 | 0.32 | 0.11 | 0.06 | 0.16 | 0.08 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 |
Interest Coverage | -5.93 | 1.60 | -78.01 | n/a | -41.14 | -167.41 | -507.82 | n/a | n/a | n/a | n/a |
Return on Equity | -0.4 | 0.35 | -16.85 | -3.35 | -0.67 | -0.65 | -0.49 | -0.37 | -0.22 | -0.18 | -0.6 |
Return on Assets | -0.04 | 0.02 | -0.15 | -0.25 | -0.14 | -0.16 | -0.15 | -0.14 | -0.1 | -0.09 | -0.24 |
Return on Invested Capital | -0.37 | n/a | -0.29 | -0.77 | -0.37 | -0.33 | -0.27 | -0.22 | -0.14 | -0.12 | -0.38 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.95 | 0.97 | 0.87 | 0.78 | 0.95 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Net Profit Margin | -0.41 | 0.05 | -1.4 | -4.42 | -0.84 | -2.08 | -3.44 | -4.98 | -3.72 | -2.87 | -6.85 |
Pretax Profit Margin | -0.41 | 0.05 | -1.32 | -4.5 | -0.85 | -2.09 | -3.44 | -4.98 | -3.72 | -2.87 | -6.85 |
Operating Profit Margin | -2.73 | 0.12 | -1.25 | -4.58 | -0.87 | -2.1 | -3.44 | -4.98 | -3.72 | -2.87 | -6.86 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | 0.11 | 0.12 | -1.25 | -4.58 | -0.82 | -2.01 | -3.34 | -4.85 | -3.6 | -2.78 | -1.24 |